These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17503124)

  • 1. Reliability and validity of neuropsychological screening and assessment strategies in MS.
    Benedict RH; Zivadinov R
    J Neurol; 2007 May; 254 Suppl 2():II22-II25. PubMed ID: 17503124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.
    Benedict RH; Munschauer F; Linn R; Miller C; Murphy E; Foley F; Jacobs L
    Mult Scler; 2003 Feb; 9(1):95-101. PubMed ID: 12617275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliable screening for neuropsychological impairment in multiple sclerosis.
    Benedict RH; Cox D; Thompson LL; Foley F; Weinstock-Guttman B; Munschauer F
    Mult Scler; 2004 Dec; 10(6):675-8. PubMed ID: 15584493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
    Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
    Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes.
    O'Brien A; Gaudino-Goering E; Shawaryn M; Komaroff E; Moore NB; DeLuca J
    Arch Clin Neuropsychol; 2007 Nov; 22(8):933-48. PubMed ID: 17851031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting neuropsychological abnormalities in multiple sclerosis.
    Benedict RH; Zivadinov R
    J Neurol Sci; 2006 Jun; 245(1-2):67-72. PubMed ID: 16626751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
    Sonder JM; Mokkink LB; van der Linden FA; Polman CH; Uitdehaag BM
    J Neurol Sci; 2012 Sep; 320(1-2):91-6. PubMed ID: 22805106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina.
    Vanotti S; Benedict RH; Acion L; Cáceres F;
    Mult Scler; 2009 Feb; 15(2):244-50. PubMed ID: 18845653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
    Dusankova JB; Kalincik T; Havrdova E; Benedict RH
    Clin Neuropsychol; 2012; 26(7):1186-200. PubMed ID: 23034066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis.
    Walker LAS; Marino D; Berard JA; Feinstein A; Morrow SA; Cousineau D
    Can J Neurol Sci; 2017 Sep; 44(5):547-555. PubMed ID: 28683843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Eshaghi A; Riyahi-Alam S; Roostaei T; Haeri G; Aghsaei A; Aidi MR; Pouretemad HR; Zarei M; Farhang S; Saeedi R; Nazeri A; Ganjgahi H; Etesam F; Azimi AR; Benedict RH; Sahraian MA
    Clin Neuropsychol; 2012; 26(6):975-84. PubMed ID: 22681459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal neuropsychological assessment of MS patients: a consensus approach.
    Benedict RH; Fischer JS; Archibald CJ; Arnett PA; Beatty WW; Bobholz J; Chelune GJ; Fisk JD; Langdon DW; Caruso L; Foley F; LaRocca NG; Vowels L; Weinstein A; DeLuca J; Rao SM; Munschauer F
    Clin Neuropsychol; 2002 Aug; 16(3):381-97. PubMed ID: 12607150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Parmenter BA; Testa SM; Schretlen DJ; Weinstock-Guttman B; Benedict RH
    J Int Neuropsychol Soc; 2010 Jan; 16(1):6-16. PubMed ID: 19796441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Benedict RH; Cookfair D; Gavett R; Gunther M; Munschauer F; Garg N; Weinstock-Guttman B
    J Int Neuropsychol Soc; 2006 Jul; 12(4):549-58. PubMed ID: 16981607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire.
    Akbar N; Honarmand K; Kou N; Levine B; Rector N; Feinstein A
    Mult Scler; 2010 Dec; 16(12):1500-6. PubMed ID: 20813773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Landi D; Palmieri MG; Moffa F; Rinaldi P; Vernieri F; Filippi MM
    Neurol Sci; 2016 Aug; 37(8):1261-70. PubMed ID: 27095052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Gromisch ES; Portnoy JG; Foley FW
    J Neurol Sci; 2018 May; 388():70-75. PubMed ID: 29627034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
    Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
    Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and Validity of a Danish Version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
    Sejbæk T; Blaabjerg M; Sprogøe P; Ravnborg M
    Int J MS Care; 2018; 20(1):49-54. PubMed ID: 29507543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.